Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Hermann Einsele (1958-)

Arzt

Name

Hermann Einsele

Time

1958- (Date of birth and death)

Place

Stuttgart (Geburtsort)
Tübingen (Wirkungsort)
Deutschland

Gender

männlich

Academic degree

Prof. Dr. med.

Profession

Arzt (characteristic profession)

Family

Gerhard Einsele (Vater)

Related

Medizinische Klinik und Poliklinik (Würzburg, 2) (2004-)
Universitätsklinikum Tübingen (-2004)

Topic

Personen zu Medizin, Tiermedizin

Further information

Arzt; Assistenzarzt am Universitätsklinikum Tübingen, 1999 Professor, 2004 Direktor der Medizinischen Klinik und Poliklinik II des Universitätsklinikums Würzburg und Lehrstuhlinhaber für Innere Medizin II der Universität Würzburg

Source

Landesbibliographie Baden-Württemberg
https://de.wikipedia.org/wiki/Hermann_Einsele (Stand: 17.05.2022)

Record type

Person

GND-Identifier

130333840

Record ID

130333840

Involved in

show all

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

Real-world analysis of teclistamab in 123 RRMM patients from Germany

CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges

Assessing osteolytic lesion size on sequential CT scans is a reliable study endpoint for bone remineralization in newly diagnosed multiple myeloma

CXCR4-targeted theranostics in hematooncology: opportunities and challenges

CXCR4-targeted theranostics in hematooncology: opportunities and challenges = CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen

Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma

Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study

Herausforderungen in der Onkologie - personalisierte Therapiesteuerung : virtuelle DGHO Frühjahrstagung 2023 : 22. Maärz 2023, 29. März 2023, 26. April 2023

Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma

Klinische Studien in der Hämatologie und Onkologie

Ärztlich assistierte Selbsttötung - Umgang mit Anfragen von Krebspatientinnen und Krebspatienten : Beiträge zur Gestaltung einer herausfordernden Praxis

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Klinische Studien in der Hämatologie und Onkologie

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns

Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry

Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

The human leukocyte antigen-DPB1 degree of compatibility is determined by its expression level and mismatch permissiveness: a german multicenter analysis

BATF3 programs CD8+ T cell memory

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness : A German Multicenter Analysis

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

Cardiovascular adverse events in modern myeloma therapy – incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma : : what to use and when

From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives

Keimarm kochen : Rezepte und Empfehlungen für Menschen mit Immunsuppression
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal